XBIRA 250 MG TABS IP

Name: XBIRA 250 MG TABS IP
Brand: CIPLA LTD (CANCER CARE)
SKU: 5308
Price: 22120.30 INR
Availability: InStock

Form: Tablet

Pack Size: 120 Tablets

Marketed by: CIPLA LTD (CANCER CARE)

MRP: ₹22120.30

Xbira 250mg by Cipla (abiraterone acetate 250 mg, 120 tablets) is a CYP17 (androgen biosynthesis) inhibitor listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists for metastatic prostate cancer, both castration-resistant and high-risk hormone-sensitive disease, given together with prednisone or prednisolone. Schedule H: dispense only against a valid prescription. Counselling point: always co-prescribed with prednisone/prednisolone; monitor LFTs, BP and potassium.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.